Park Ha Biological Technology reported revenue of -$62781.00 for the quarter ended Apr 2026. This income statement covers 5 quarters of results from Oct 2023 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Oct2023 | Oct2024 | Apr2025 | Oct2025 | Apr2026 |
|---|---|---|---|---|---|
| Revenue & cost | |||||
| Revenue | 14,902.00 | -62781.00 | |||
| Additional items | |||||
| Shares Outstanding | 62,500.00 | 62,500.00 | 62,500.00 | 73,608.00 | 73,608.00 |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 62,500.00 | 62,500.00 | 62,500.00 | 73,608.00 | 73,608.00 |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 62,500.00 | 62,500.00 | 84,686.00 |